Keros Therapeutics, Inc. — SCHEDULE 13G Filings
6 SCHEDULE 13G filings on record
This page lists all SCHEDULE 13G filings submitted to the SEC by Keros Therapeutics, Inc. (KROS), sorted by most recent first. Each row links to the full filing on EdgarLookup. Keros Therapeutics, Inc. has filed 6 SCHEDULE 13G documents with the SEC since 2016. To view all SEC filings by Keros Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
3
3/A
4
4/A
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
POS EX
S-1
S-1/A
S-1MEF
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-I
SC TO-I/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G | — | 0000905148-25-004126 | Nov 18, 2025 | — |
| SCHEDULE 13G | — | 0001104659-25-102591 | Oct 27, 2025 | — |
| SCHEDULE 13G | — | 0001214659-25-015219 | Oct 22, 2025 | — |
| SCHEDULE 13G | — | 0001013594-25-000650 | May 14, 2025 | — |
| SCHEDULE 13G | — | 0000932471-25-000637 | Apr 30, 2025 | — |
| SCHEDULE 13G | — | 0000902664-25-001043 | Feb 14, 2025 | — |